A Training Program of Drug Allergy for Healthcare Professionals

Drug Allergy Clinical Trial

Official title:

A Training Program of Drug Allergy for Healthcare Professionals: A Randomized Controlled Trial

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06399601
• Other study ID #: Drugallergy
• Status: Not yet recruiting
• Phase: N/A
• Start date: December 9, 2024
• Est. completion date: December 16, 2024

Study information

• Verified date: April 2024
• Source: The University of Hong Kong
• Contact: Hei Li, MBBS
• Phone: 2255 5995
• Email: liphilip[@]hku.hk
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Drug allergy is often under-recognized, yet over- (mistakenly) diagnosed, especially in Hong Kong. There is also a dire shortage of allergy specialists and facilities to tackle the overwhelming drug allergy pandemic. Fortunately, when trained, non-specialist physicians and nurses have demonstrated comparable capabilities in drug allergy evaluation compared to specialists. To potentially promote and propagate the role of non-specialist physicians and nurses toward drug allergy care, the investigators propose a study to investigate the impact of an intensive and focused drug allergy educational course conducted at the University of Hong Kong.

Description:

Two identical didactic courses on drug allergy were designed. Each course will last 12 hours and conducted over 2 consecutive days (6 hours each day). All candidates will attend physically and on-site. Various aspects of drug allergy with pre-set learning objectives will be taught in-person by instructors (physicians or nurses specializing in drug allergy nominated by the University of Hong Kong). Course materials and instructors will be identical for each course.

Aims of the study Primary objective

• Investigate the change in knowledge among participants of a 2-day drug allergy educational course

• Investigate the change in clinical practice among participants of a 2-day drug allergy educational course

Secondary objectives

• Investigate the sustained change(s) in knowledge (if any) of participants of a 2-day drug allergy educational course

• Investigate the sustained change(s) in clinical practice (if any) of participants of a 2-day drug allergy educational course

Hypothesis The investigators hypothesize that candidates (practicing physicians and nurses) of the drug allergy course will gain knowledge on drug allergy, which in turn will influence and change their clinical practice.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 100
• Est. completion date: December 16, 2024
• Est. primary completion date: December 16, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Registered nurses or doctors actively practicing in Hong Kong

• English speaking;

• Able to complete quizzes and questionnaires;

• Aged 18 or above

Exclusion Criteria:

• People who are unable to communicate in Cantonese or Mandarin

• People who are participating in other drug allergy training course

Related Conditions & MeSH terms

• Drug Allergy
• Drug Hypersensitivity
• Hypersensitivity

Intervention

Other:
• Drug allergy training program
Two identical didactic courses on drug allergy were designed. Each course will last 12 hours and conducted over 2 consecutive days (6 hours each day). All candidates will attend physically and on-site. Various aspects of drug allergy with pre-set learning objectives will be taught in-person by instructors (physicians or nurses specializing in drug allergy nominated by the University of Hong Kong). Course materials and instructors will be identical for each course.

Locations

Country	Name	City	State
Hong Kong	School of Biomedical Science	Hong Kong

Sponsors (1)

Lead Sponsor	Collaborator
The University of Hong Kong

Country where clinical trial is conducted

Hong Kong, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in knowledge of drug allergy as measured by the validated drug allergy questionnaire	Knowledge includes mechanism, clinical manifestations, diagnosis and management of drug allergy. A binary variable scale were used to ascertain level of the knowledge (from 0 to 1: 0, wrong; 1, right). Answers formats consisted of 4-choice questions (total 14 questions).	After the 2-day training course